CVS to buy home health giant Signify Health for about $8 billion

CVS to buy home health giant Signify Health for about  billion


A CVS logo is displayed at one of their stores near Bloomsburg.

Paul Weaver | Lightrocket | Getty Images

CVS Health has reached a deal to acquire in-home health-care company Signify Health for about $8 billion, the companies said Monday.

CVS said it will pay $30.50 a share in cash for Signify, an acquisition that would build on its growing health-care services. Signify provides technology and analytics to help with in-home patient care.

“This acquisition will enhance our connection to consumers in the home and enables providers to better address patient needs as we execute our vision to redefine the health care experience,” CVS Health President and CEO Karen Lynch said in a news release.

The deal comes as competitors from Amazon to Walgreens are moving further into the health-care sector. In July, Amazon announced it was acquiring primary-care provider One Medical for about $3.9 billion.

Signify Health’s shares have surged nearly 45% over the last month to give it a market value of about $6.7 billion at $28.77 a share as of Friday’s close, according to FactSet. The Wall Street Journal reported on Aug. 2 that Signify was exploring strategic alternatives, including a sale.

Shares of Signify, which went public in February 2021, surged in late August after reports that Amazon was among the bidders.

Last month, CVS revealed plans to acquire or take a stake in a primary-care company by year’s end.

The Signify deal follows other acquisitions and shifts into primary health care. CVS previously acquired insurer Aetna and pharmacy benefits manager Caremark, and customers can get vaccines or urgent care at MinuteClinic outposts inside of its stores. It recently introduced therapy for mental health at some stores.

The companies expect the acquisition, which is subject to regulatory approval, to close in the first half of next year.

Private equity firm New Mountain Capital owns about 60% of Signify’s common stock and agreed to support the deal, the companies said.

CVS Health and Signify Health will hold an analyst and investor call at 8:30 a.m. ET on Tuesday to discuss the transaction.



Source

Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure
Health

Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure

The office building of international biopharmaceutical company AstraZeneca. Cfoto | Future Publishing | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. President Donald Trump has been pressuring pharmaceutical companies to lower U.S. drug […]

Read More
Trump’s pharmaceutical tariffs could affect some drugmakers more than others
Health

Trump’s pharmaceutical tariffs could affect some drugmakers more than others

Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer | Getty Images President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and the duties may have a bigger impact on some drugmakers than others, according to some […]

Read More
Merck plans  billion cost cuts by end of 2027, narrows full-year outlook
Health

Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook

Merck & Co. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Tuesday, April 8, 2025. Michael Nagle | Bloomberg | Getty Images Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches […]

Read More